Neogen
NEOG • NASDAQ
Neogen is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Mikhael Nassif, with a market cap of $1.9B.
CEOMikhael Nassif
Next Earnings
Upcoming earnings announcement for Neogen
Date
Monday, April 13, 2026 (in 1 week)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q3 2026
EPS Estimate
$0.04
Revenue Estimate
$204.6M
Earnings History
Past 12 earnings reports for Neogen
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 8, 2026 | Q2 2026 | $0.10Est: $0.06 | +66.7% | $224.7MEst: $208.9M | +7.5% |  10-Q |
| Oct 9, 2025 | Q1 2026 | $0.04Est: $0.03 | +33.3% | $209.2MEst: $203.8M | +2.7% | 10-Q |
| Jul 29, 2025 | Q4 2025 | $0.05Est: $0.08 | -37.5% | $225.5MEst: $222.0M | +1.5% | 10-K |
| Apr 9, 2025 | Q3 2025 | $0.10Est: $0.13 | -23.1% | $221.0MEst: $223.0M | -0.9% | 10-Q |
| Jan 10, 2025 | Q2 2025 | $0.11Est: $0.10 | +10.0% | $231.3MEst: $228.1M | +1.4% | 10-Q |
| Oct 10, 2024 | Q1 2025 | $0.07Est: $0.08 | -12.5% | $217.0MEst: $215.1M | +0.9% | 10-Q |
| Jul 30, 2024 | Q4 2024 | $0.10Est: $0.11 | -9.1% | $236.8MEst: $224.8M | +5.4% | 10-K |
| Apr 9, 2024 | Q3 2024 | $0.12Est: $0.14 | -14.3% | $228.8MEst: $230.0M | -0.5% | 10-Q |
| Jan 9, 2024 | Q2 2024 | $0.11Est: $0.14 | -21.4% | $229.6MEst: $232.9M | -1.4% | 10-Q |
| Oct 10, 2023 | Q1 2024 | $0.11Est: $0.12 | -8.3% | $229.0MEst: $231.1M | -0.9% | 10-Q |
| Jul 27, 2023 | Q4 2023 | $0.14Est: $0.10 | +40.0% | $241.8MEst: $227.7M | +6.2% | — |
| Mar 30, 2023 | Q3 2023 | $0.12Est: -$0.01 | +1300.0% | $218.3MEst: $218.9M | -0.3% | — |